Hospital Sultanah Bahiyah Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2011
NCT01091701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital Sultanah Bahiyah | Hospital Sultanah Bahiyah Consultant Physician, Medical Department, Km 6 Jalan Langgar, 5460 Alor Setar, Kedah | Hospital Sultanah Bahiyah, Ministry of Health Malaysia | Muhammad Radzi Abu Hassan

Active Ingredients

Drugs in Phase 3 Trials (2)

ravidasvir (1 trial)

sofosbuvir (sovaldi) (1 trial)

Drugs in Phase 2 Trials (1)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3